Daniel P. Florin - 25 Jun 2021 Form 4 Insider Report for Pulmonx Corp (LUNG)

Role
Director
Signature
/s/ Lauren Cristina, Attorney-in-Fact for Daniel Philip Florin
Issuer symbol
LUNG
Transactions as of
25 Jun 2021
Net transactions value
+$98,035
Form type
4
Filing time
28 Jun 2021, 17:33:25 UTC
Previous filing
11 Jun 2021
Next filing
13 Jul 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUNG Common Stock Purchase $98,035 +2,222 +79% $44.12 5,032 25 Jun 2021 Direct F1, F2
holding LUNG Common Stock 15,789 25 Jun 2021 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2021.
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $43.68 to $44.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
F3 The shares are directly held by Kelly A Florin Trust, for which the Reporting Person is a trustee.